Investigators pooled patient-level data from 16 cohorts and trials to derive a bleeding-risk model after catheter-directed thrombolysis for acute pulmonary embolism. Among 1,246 patients without thrombolysis contraindications, 75 (6.0%) had major bleeding, including 10 intracranial hemorrhages. F-HARP incorporates female sex, hypertension, age and high-risk pulmonary embolism. In an independent 566-patient cohort, 30-day major bleeding occurred in 11.2% classified as high risk versus 3.8% of others (OR 3.18, 95% CI 1.44–7.05). External discrimination was modest: AUROC 0.638 (95% CI 0.519–0.742), with calibration slope 0.630 (95% CI 0.153–1.107).
F-HARP identified a subgroup with higher bleeding odds after catheter-directed thrombolysis, but modest external discrimination limits confidence in individual predictions. Powered external validation remains necessary before precise risk quantification.
Study limitation: External discrimination and calibration estimates were imprecise; the authors explicitly call for powered external validation.
AI-generated from the published abstract with automated source checks. For research discovery; consult the original paper before applying findings.